AHA Coding Clinic® for HCPCS - 2021 Quarter 4; For Your Information
New CPT codes for the COVID-19 vaccines
The American Medical Association (AMA) released new product and administration codes for the Pfizer, Moderna and Janssen Pharmaceutical (a division of Johnson & Johnson) COVID-19 vaccines. New product codes The new CPT code released to capture Pfizer’s new ready-to-use vaccine product is CPT code 91305 , Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use. The new ready-to-use two-dose vaccine does not require the use of a diluent or require storage at extremely low temperatures. The administration codes that were created for...
Subscribe or sign in to view the full article.
Article Overview
This article reviews recent AMA CPT coding updates tied to COVID-19 vaccine products and administration services. It is aimed at coders, billers, and compliance staff who need to track vaccine-related CPT changes, effective dates, and guidance issued by AMA and referenced federal agencies. The article also points readers to sources for ongoing updates as vaccine coding continues to evolve.
Why This Topic Matters
COVID-19 vaccine coding changed frequently, with new product and administration codes tied to different vaccine formulations, dosing scenarios, and age groups. Understanding these updates helps support accurate reporting, claims processing, and alignment with evolving AMA and federal guidance.
Article Sections
-
New product codes
Covers the introduction of new vaccine product coding for updated COVID-19 vaccine formulations and the related administration code groupings.
-
New administration codes for the booster dose
Summarizes administration code updates connected to booster-dose reporting and distinguishes them from other dose scenarios discussed in the article.
-
New pediatric product and administration codes
Addresses vaccine coding updates related to pediatric COVID-19 vaccination and the timing of the new codes.
What You Will Learn
- How the article organizes recent COVID-19 vaccine CPT updates
- Which general vaccine scenarios are covered by the coding changes
- What organizations and resources are referenced for ongoing vaccine coding guidance
- How the article distinguishes adult booster and pediatric vaccine updates at a high level
Who Should Read This
- Medical coders
- Billing staff
- Compliance professionals
- Revenue cycle teams
- Health care organizations
- Pediatric and adult vaccine providers
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com